{"id":"W2530252650","doi":"10.1182/blood.v124.21.3344.3344","title":"Comparison of Outcomes in Chronic Lymphocytic Leukemia (CLL) with the Addition of Rituximab to Initial Treatment: A Comparative Effectiveness Analysis in the Province of British Columbia (BC), Canada","year":2014,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"St. Paul's Hospital; Vancouver General Hospital; BC Cancer Agency; University of British Columbia","funders":"","keywords":"Medicine; Chemoimmunotherapy; Internal medicine; Chronic lymphocytic leukemia; Rituximab; Hazard ratio; Population; Alemtuzumab; Proportional hazards model; Cohort; Oncology; Progression-free survival; Fludarabine; Chemotherapy; Cyclophosphamide; Leukemia; Lymphoma; Confidence interval; Transplantation","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006597261,0.0005357915,0.001315766,0.001245751,0.0007408342,0.001384719,0.001176321,0.0006991206,0.001581736],"category_scores_gemma":[0.01753446,0.0002428632,0.001985597,0.002836785,0.0007604032,0.0003292409,0.000715898,0.0007609113,0.00007047388],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.02851096,"about_ca_system_score_gemma":0.02559148,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.8682948,"about_ca_topic_score_gemma":0.9017665,"domain_scores_codex":[0.9916735,0.005113372,0.0004900329,0.00042023,0.001612754,0.0006901736],"domain_scores_gemma":[0.9889116,0.004642208,0.002042302,0.0003219293,0.002482907,0.001598958],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.2520393,0.003358914,0.5598532,0.00665292,0.02523433,0.0002765972,0.0007782184,0.01154447,0.001531216,0.001656228,0.007678891,0.1293957],"study_design_scores_gemma":[0.03159646,0.0314277,0.896189,0.001288614,0.01864265,0.0002449064,0.001822713,0.01061537,0.0008133682,0.0005461412,0.006661889,0.0001511649],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9756327,0.01488081,0.0004387013,0.0005556153,0.0000732476,0.000732997,0.003841078,0.00001453317,0.003830251],"genre_scores_gemma":[0.9947166,0.002408461,0.0004763811,0.000221789,0.00002711557,0.0002283918,0.001543059,0.000005378273,0.0003728444],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1317052,"threshold_uncertainty_score":0.2649617,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01773383806693,"score_gpt":0.3142880667871178,"score_spread":0.2965542287201878,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}